Wednesday
Jun202007

NCT00490529

Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

Conditions: Lymphoma, Mantle-Cell
Sponsors: Stanford University
Phase II

PrintView Printer Friendly Version

EmailEmail Article to Friend

References (1)

References allow you to track sources for this article, as well as articles that were written in response to this article.